Jon Congleton, Mineralys CEO
Months removed from a $118M Series B, Mineralys pushes ahead with PhII hypertension data
In June, the Philadelphia-based biotech Mineralys completed a $118 million Series B financing with backing from names like RA Capital, pushing toward finishing a …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
